FDA Defends Approval of Controversial Alzheimer’s Drug

Published on June 8, 2021

The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer’s disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science. Aduhelm (aducanumab) treats Alzheimer’s by clearing out…

Read Full Article (External Site)